Patent ID: 6706737
Filing Date: 2004-03-16
Classification: A61K,A61P,C07D,G01N

Abstract:
A composition present in a solid state comprising a plurality of complexes, wherein each complex comprises:(a) at least one molecule of a compound represented by the formula (Ia): wherein:Sx represents a chiral sulfur atom comprising at least one of the diastereomers represented by Sxa and Sxb, wherein Sxa is the (âˆ’) diasteromer and Sxb is the (+) diasteromer; R is alkoxy; R1 is selected from the group consisting of hydrogen, alkyl, halogen, carboalkoxy, alkoxy, and alkanoyl R2 is hydrogen or alkyl; R3, R4, and R5 may be the same or different and are each selected from the group consisting of hydrogen, alkyl, alkoxy, and alkoxyalkoxy, wherein when R4 is alkoxy and R3 and R5 are not hydrogen, the alkyl substituent of such alkoxy group is selected from the group consisting of at least one of the diastereomers represented by R4q and R4z, wherein R4q is the (âˆ’) diastereomer and lies above the chiral plane; and R4z is the (+) diastereomer and lies below the chiral plane; and (b) at least one additional molecule of a compound represented by the formula (Ia) or a compound represented by the formula (Ib) wherein: Sx represents a chiral sulfur atom comprising at least one of the diastereomers represented by Sxa and Sxb, wherein Sxa is the (âˆ’) diasteromer and Sxb is the (+) diasteromer; R is alkoxy; R1 is selected from the group consisting of hydrogen, alkyl, halogen, carboalkoxy, alkoxy, and alkanoyl R2 is hydrogen or alkyl; R3, R4, and R5 may be the same or different and are each selected from the group consisting of hydrogen, alkyl, alkoxy, and alkoxyalkoxy, wherein when R4 is alkoxy and R3 and R5 are not hydrogen, the alkyl substituent of such alkoxy group is selected from the group consisting of at least one of the diastereomers represented by R4q and R4z, wherein R4q is the (âˆ’) diastereomer and lies above the chiral plane; and R4z is the (+) diastereomer and lies below the chiral plane, or one or more pharmaceutically acceptable salts, solvates, hydrates, or combinations thereof with said compounds being the same or different, or one or more pharmaceutically acceptable salts, hydrates, or combinations thereof; and at least one atom of a metal cation for each of said two molecules of said compound, wherein the metal cation is magnesium.